4
Changes in Ownership
FATE THERAPEUTICS INC Filed Acc 0000950170-24-003650
Chief R&D Officer sold 11,271 shares at $4.38 ($49,367)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Valamehr Bahram Chief R&D Officer | 2024-01-09 | Sale | −11,271 | $4.38 | $49,367 | 158,069 | D |
| Open-market sales · 11,271 sh · avg $4.38 · $49,367 | |||||||
Loading xslF345X05/ownership.xml…